Analysis of the economic and health consequences following the implementation of ‘targeted’ therapy for metastatic renal cell carcinoma (2015)

Conducted for KORA and Anne Vest Sørensen (PHD student at Herlev and Gentofte Hospital, Denmark)

Analysis of the economic and health consequences of the implementation of ‘targeted’ therapy for metastatic renal cell carcinoma based on Danish data analysis.

i2minds contributed to the project by establishing the analysis design and methodology, implementing data processing and static analyses for use in, among other things, the article: “Health Economic Changes as a Result of Implementation of Targeted Therapy for Metastatic Renal Cell Carcinoma: National Results from DARENCA Study 2” (European Urology 12/2014), where Rikke Ibsen, i2minds, is co-author – link to article overview

In this project, i2minds provided data analysis and a presentation product for communication purposes. The combination of an almost obsessive approach to data and strong communicative skills means that I can completely rely on the results. At i2minds, there is always room for differences, which makes for a relaxed atmosphere. Rikke and Michael employ a systematic, independent approach to their work and always deliver.

Jakob Kjellberg Professor, Programme Director for Health, MSc., Health Econ., KORA